DistantNews
Support us
๐Ÿ‡น๐Ÿ‡ผ Taiwan /Crime & Justice

City Hall Denies Falsifying Data After Media Personality Questions Oil Inspection

From Liberty Times · () Chinese

Translated from Chinese, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Context piece
  • Media personality Wen Lang-tung questioned the city government's 2024 inspection of Chung-Lien Oil, alleging it did not test for benzo(a)pyrene.
  • The city government stated that the inspection report from the Food and Drug Administration (FDA) confirmed Chung-Lien's benzo(a)pyrene levels were compliant, thus it was not listed.
  • The government clarified that inspection items are designated by the central FDA, and its 2024 report indicated compliance for Chung-Lien's product.

Media personality Wen Lang-tung has publicly questioned the Taichung City Government's inspection of Chung-Lien Oil, a major soybean oil producer. Wen alleged that a city government inspection on April 26, 2024, did not include testing for benzo(a)pyrene (BaP), a polycyclic aromatic hydrocarbon.

Wen pointed out that while the city's report lacked this test, information received by the Ministry of Health and Welfare (MOHW) on the same day indicated that the same batch of soybean salad oil from Chung-Lien was compliant for BaP. This discrepancy led Wen to question whether the city government fabricated data or if the MOHW's data was erroneous.

The Taichung City Government responded by stating that inspection items are determined by the central FDA. For the 2024 fiscal year, the FDA sent samples from various oil manufacturers, including Chung-Lien, to SGS for testing. The FDA then provided the results to the city government. According to the FDA's report, Chung-Lien's product met the standards for benzo(a)pyrene, which is why it was not specifically listed on the city's website as a tested item.

The government further clarified that a joint inspection project in January 2025, initiated by the MOHW's FDA, involved testing 13 manufacturers for BaP. The city emphasized that the list of manufacturers for that specific project was designated by the central FDA, and Wen's assertion that Chung-Lien was not tested in that instance was a misunderstanding, suggesting he should direct his inquiry to the central FDA.

DistantNews Editorial

Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.